Skip to main content
Erschienen in: Journal of Gastrointestinal Surgery 8/2019

13.06.2019

Safety and Efficacy of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma (3–5 cm): a Propensity Score Matching Cohort Study

verfasst von: Qing-wang Ye, Shu-jie Pang, Ning Yang, Hai-bin Zhang, Yong Fu, Bin Lin, Guang-shun Yang

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 8/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

We aim to investigate the safety and efficacy of radiofrequency ablation in the treatment of solitary hepatocellular carcinoma (3–5 cm) in comparison with surgical resection.

Methods

Included in this study were 388 patients with primary and solitary hepatocellular carcinoma, of whom 196 patients underwent surgical resection and the other 192 patients received radiofrequency ablation. Clinicopathological characteristics, prognosis, post-treatment complications, hospital stay, and financial expenditures between the two groups were compared retrospectively.

Results

The result of propensity score matching and subgroup analysis showed that the 1-, 3-, and 5-year overall survival and disease-free survival were comparable in patients with tumors of 3–4 cm in diameter between surgical resection and radiofrequency ablation groups. However, when the tumor size exceeded 4 cm in diameter, surgical resection exhibited a superior long-term prognosis compared with radiofrequency ablation. Nevertheless, hepatectomy was associated with high occurrences of postoperative complications, long hospital stay, and high hospitalization cost as compared with radiofrequency ablation. Further analysis of the relationship between tumor size and pathological features of hepatocellular carcinoma showed that tumors larger than 4 cm were positively correlated with a high rate of microvascular invasion and satellite nodule formation.

Conclusion

For solitary hepatocellular carcinoma of 3–4 cm in diameter, radiofrequency ablation could achieve a comparable prognosis with a low incidence of post-treatment complications and low hospitalization costs, while surgical resection is recommended for solitary hepatocellular carcinoma tumors of 4–5 cm in diameter when long-term prognosis is considered.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Torre LA, Bray F, Siegel RL, et al. Global Cancer Statistics, 2012. CA-Cancer J Clin. 2015;65(2):87–108.CrossRefPubMed Torre LA, Bray F, Siegel RL, et al. Global Cancer Statistics, 2012. CA-Cancer J Clin. 2015;65(2):87–108.CrossRefPubMed
2.
4.
Zurück zum Zitat Tanaka M, Katayama F, Kato H, et al. Hepatitis B and C Virus Infection and Hepatocellular Carcinoma in China: A Review of Epidemiology and Control Measures. J Epidemiol. 2011;21(6):401–16.CrossRefPubMedPubMedCentral Tanaka M, Katayama F, Kato H, et al. Hepatitis B and C Virus Infection and Hepatocellular Carcinoma in China: A Review of Epidemiology and Control Measures. J Epidemiol. 2011;21(6):401–16.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat McGlynn KA, Petrick JL, London WT. Global Epidemiology of Hepatocellular Carcinoma An Emphasis on Demographic and Regional Variability. Clinics in liver disease. 2015;19(2):223–238.CrossRefPubMedPubMedCentral McGlynn KA, Petrick JL, London WT. Global Epidemiology of Hepatocellular Carcinoma An Emphasis on Demographic and Regional Variability. Clinics in liver disease. 2015;19(2):223–238.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Tian QJ, Jia JD. Hepatitis B virus genotypes: epidemiological and clinical relevance in Asia. Hepatology International. 2016;10(6):854–60.CrossRefPubMed Tian QJ, Jia JD. Hepatitis B virus genotypes: epidemiological and clinical relevance in Asia. Hepatology International. 2016;10(6):854–60.CrossRefPubMed
7.
Zurück zum Zitat Bruix J, Reig M, Sherman M. Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma. Gastroenterology. 2016;150(4):835–53.CrossRefPubMed Bruix J, Reig M, Sherman M. Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma. Gastroenterology. 2016;150(4):835–53.CrossRefPubMed
8.
Zurück zum Zitat de Lope CR, Tremosini S, Forner A,et al. Management of HCC. Journal of hepatology. 2012;56:S75-S87.CrossRefPubMed de Lope CR, Tremosini S, Forner A,et al. Management of HCC. Journal of hepatology. 2012;56:S75-S87.CrossRefPubMed
9.
Zurück zum Zitat Lee SH, Jin YJ, Lee JW. Survival benefit of radiofrequency ablation for solitary (3-5cm) hepatocellular carcinoma: An analysis for nationwide cancer registry. Medicine. 2017;96(44):7. Lee SH, Jin YJ, Lee JW. Survival benefit of radiofrequency ablation for solitary (3-5cm) hepatocellular carcinoma: An analysis for nationwide cancer registry. Medicine. 2017;96(44):7.
10.
Zurück zum Zitat Xu XL, Liu XD, Liang M, Luo BM. Radiofrequency Ablation versus Hepatic Resection for Small Hepatocellular Carcinoma: Systematic Review of Randomized Controlled Trials with Meta-Analysis and Trial Sequential Analysis. Radiology. 2018;287(2):461–72.CrossRefPubMed Xu XL, Liu XD, Liang M, Luo BM. Radiofrequency Ablation versus Hepatic Resection for Small Hepatocellular Carcinoma: Systematic Review of Randomized Controlled Trials with Meta-Analysis and Trial Sequential Analysis. Radiology. 2018;287(2):461–72.CrossRefPubMed
11.
Zurück zum Zitat Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo Classification of Surgical Complications Five-Year Experience. Annals of Surgery. 2009;250(2):187–96.CrossRefPubMed Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo Classification of Surgical Complications Five-Year Experience. Annals of Surgery. 2009;250(2):187–96.CrossRefPubMed
12.
Zurück zum Zitat Guo WX, Zhai B, Lai ECH, Li N, Shi J, Lau WY, et al. Percutaneous Radiofrequency Ablation versus Partial Hepatectomy for Multicentric Small Hepatocellular Carcinomas: A Nonrandomized Comparative Study. World Journal of Surgery. 2010;34(11):2671–6.CrossRefPubMed Guo WX, Zhai B, Lai ECH, Li N, Shi J, Lau WY, et al. Percutaneous Radiofrequency Ablation versus Partial Hepatectomy for Multicentric Small Hepatocellular Carcinomas: A Nonrandomized Comparative Study. World Journal of Surgery. 2010;34(11):2671–6.CrossRefPubMed
13.
Zurück zum Zitat Kulik L, Heimbach JK, Zaiem F, et al. Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta-analysis. Hepatology. 2018;67(1):381–400.CrossRefPubMed Kulik L, Heimbach JK, Zaiem F, et al. Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta-analysis. Hepatology. 2018;67(1):381–400.CrossRefPubMed
14.
Zurück zum Zitat Lu H, Lu L, Zhang F,et al. Living donor liver transplantation: where do we stand and where are we going? Hepatobiliary Surgery and Nutrition. 2016;5(2):141–4.PubMedPubMedCentral Lu H, Lu L, Zhang F,et al. Living donor liver transplantation: where do we stand and where are we going? Hepatobiliary Surgery and Nutrition. 2016;5(2):141–4.PubMedPubMedCentral
15.
Zurück zum Zitat Chen SL, Peng ZW, Lin MX, et al. Combined percutaneous radiofrequency ablation and ethanol injection versus hepatic resection for 2.1-5.0 cm solitary hepatocellular carcinoma: a retrospective comparative multicentre study. Eur Radiol. 2018;28(9):3651–60.CrossRefPubMed Chen SL, Peng ZW, Lin MX, et al. Combined percutaneous radiofrequency ablation and ethanol injection versus hepatic resection for 2.1-5.0 cm solitary hepatocellular carcinoma: a retrospective comparative multicentre study. Eur Radiol. 2018;28(9):3651–60.CrossRefPubMed
16.
Zurück zum Zitat Peng ZW, Lin XJ, Zhang YJ, et al. Radiofrequency Ablation versus Hepatic Resection for the Treatment of Hepatocellular Carcinomas 2 cm or Smaller: A Retrospective Comparative Study. Radiology. 2012;262(3):1022–33.CrossRefPubMed Peng ZW, Lin XJ, Zhang YJ, et al. Radiofrequency Ablation versus Hepatic Resection for the Treatment of Hepatocellular Carcinomas 2 cm or Smaller: A Retrospective Comparative Study. Radiology. 2012;262(3):1022–33.CrossRefPubMed
17.
Zurück zum Zitat Lupo L, Panzera P, Giannelli G, et al. Single hepatocellular carcinoma ranging from 3 to 5 cm: radiofrequency ablation or resection? HPB : the official journal of the International Hepato Pancreato Biliary Association. 2007;9(6):429–34.CrossRef Lupo L, Panzera P, Giannelli G, et al. Single hepatocellular carcinoma ranging from 3 to 5 cm: radiofrequency ablation or resection? HPB : the official journal of the International Hepato Pancreato Biliary Association. 2007;9(6):429–34.CrossRef
18.
Zurück zum Zitat Banerjee S, Wang DS, Kim HJ, et al. A Computed Tomography Radiogenomic Biomarker Predicts Microvascular Invasion and Clinical Outcomes in Hepatocellular Carcinoma. Hepatology. 2015;62(3):792–800.CrossRefPubMedPubMedCentral Banerjee S, Wang DS, Kim HJ, et al. A Computed Tomography Radiogenomic Biomarker Predicts Microvascular Invasion and Clinical Outcomes in Hepatocellular Carcinoma. Hepatology. 2015;62(3):792–800.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Sumie S, Kuromatsu R, Okuda K, et al. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors. Annals of Surgical Oncology. 2008;15(5):1375–82.CrossRefPubMed Sumie S, Kuromatsu R, Okuda K, et al. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors. Annals of Surgical Oncology. 2008;15(5):1375–82.CrossRefPubMed
20.
Zurück zum Zitat Finn RS, Zhu AX, Farah W, et al. Therapies for advanced stage hepatocellular carcinoma with macrovascular invasion or metastatic disease: A systematic review and meta-analysis. Hepatology. 2018;67(1):422–35.CrossRefPubMed Finn RS, Zhu AX, Farah W, et al. Therapies for advanced stage hepatocellular carcinoma with macrovascular invasion or metastatic disease: A systematic review and meta-analysis. Hepatology. 2018;67(1):422–35.CrossRefPubMed
21.
Zurück zum Zitat Kaibori M, Ishizaki M, Matsui K, Kwon AH. Predictors of Microvascular Invasion Before Hepatectomy for Hepatocellular Carcinoma. Journal of Surgical Oncology. 2010;102(5):462–8.CrossRefPubMed Kaibori M, Ishizaki M, Matsui K, Kwon AH. Predictors of Microvascular Invasion Before Hepatectomy for Hepatocellular Carcinoma. Journal of Surgical Oncology. 2010;102(5):462–8.CrossRefPubMed
22.
Zurück zum Zitat Roayaie S, Blume IN, Thung SN, et al. A System of Classifying Microvascular Invasion to Predict Outcome After Resection in Patients With Hepatocellular Carcinoma. Gastroenterology. 2009;137(3):850–5.CrossRefPubMedPubMedCentral Roayaie S, Blume IN, Thung SN, et al. A System of Classifying Microvascular Invasion to Predict Outcome After Resection in Patients With Hepatocellular Carcinoma. Gastroenterology. 2009;137(3):850–5.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Cucchetti A, Piscaglia F, Grigioni AD, et al. Preoperative prediction of hepatocellular carcinoma tumour grade and micro-vascular invasion by means of artificial neural network: A pilot study. Journal of hepatology. 2010;52(6):880–8.CrossRefPubMed Cucchetti A, Piscaglia F, Grigioni AD, et al. Preoperative prediction of hepatocellular carcinoma tumour grade and micro-vascular invasion by means of artificial neural network: A pilot study. Journal of hepatology. 2010;52(6):880–8.CrossRefPubMed
24.
Zurück zum Zitat Hwang S, Lee YJ, Kim KH, et al. The Impact of Tumor Size on Long-Term Survival Outcomes After Resection of Solitary Hepatocellular Carcinoma: Single-Institution Experience with 2558 Patients. J Gastrointest Surg. 2015;19(7):1281–90.CrossRefPubMed Hwang S, Lee YJ, Kim KH, et al. The Impact of Tumor Size on Long-Term Survival Outcomes After Resection of Solitary Hepatocellular Carcinoma: Single-Institution Experience with 2558 Patients. J Gastrointest Surg. 2015;19(7):1281–90.CrossRefPubMed
25.
Zurück zum Zitat McHugh PP, Gilbert J, Vera S,et al. Alpha-fetoprotein and tumour size are associated with microvascular invasion in explanted livers of patients undergoing transplantation with hepatocellular carcinoma. Hpb. 2010;12(1):56–61CrossRefPubMedPubMedCentral McHugh PP, Gilbert J, Vera S,et al. Alpha-fetoprotein and tumour size are associated with microvascular invasion in explanted livers of patients undergoing transplantation with hepatocellular carcinoma. Hpb. 2010;12(1):56–61CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Huang G, Lau WY, Zhou WP, et al. Prediction of Hepatocellular Carcinoma Recurrence in Patients With Low Hepatitis B Virus DNA Levels and High Preoperative Hepatitis B Surface Antigen Levels. Jama Surgery. 2014;149(6):519–27.CrossRefPubMed Huang G, Lau WY, Zhou WP, et al. Prediction of Hepatocellular Carcinoma Recurrence in Patients With Low Hepatitis B Virus DNA Levels and High Preoperative Hepatitis B Surface Antigen Levels. Jama Surgery. 2014;149(6):519–27.CrossRefPubMed
Metadaten
Titel
Safety and Efficacy of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma (3–5 cm): a Propensity Score Matching Cohort Study
verfasst von
Qing-wang Ye
Shu-jie Pang
Ning Yang
Hai-bin Zhang
Yong Fu
Bin Lin
Guang-shun Yang
Publikationsdatum
13.06.2019
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 8/2019
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-019-04229-6

Weitere Artikel der Ausgabe 8/2019

Journal of Gastrointestinal Surgery 8/2019 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.